Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eledon Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 30.9K | $233K | $1.55 | Jan 10, 2025 | Direct |
Eledon Pharmaceuticals, Inc. | Director | Restricted Stock Units | 3.43K | Jan 10, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELDN | Eledon Pharmaceuticals, Inc. | Jan 10, 2025 | 2 | $0 | 4 | Jan 13, 2025 | Director |
ELDN | Eledon Pharmaceuticals, Inc. | May 1, 2023 | 1 | $0 | 4 | May 2, 2023 | Director |
ELDN | Eledon Pharmaceuticals, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 2, 2023 | Director |
ELDN | Eledon Pharmaceuticals, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Director |
ELDN | Eledon Pharmaceuticals, Inc. | Jul 1, 2021 | 0 | $0 | 3 | Jul 9, 2021 | Director |